Background: Faecal microbiota transplantation (FMT) is an effective treatment of recurrent Clostridioides difficile infection (rCDI) and is being applied experimentally in other diseases. Encapsulated administration may be equivalent in efficacy to delivery through other routes. Methods: A systematic review was undertaken of studies using encapsulated FMT up to 26 October 2020. Data on indication, clinical outcomes, safety, treatment protocol and capsule preparation were collected and reported. Pooled rates of clinical efficacy in rCDI were calculated using random-effects meta-analysis. The impact of single variables on clinical efficacy was evaluated using univariate meta-regression. Results: A total of 35 studies reporting the treatment o...
ObjectivesAlthough systematic evaluation has confirmed the efficacy of fresh fecal microbiota transp...
Introduction: The role of the gut microbiota in health and the pathogenesis of several diseases has ...
Clostridioides difficile infection (CDI) presents a major global healthcare challenge. Recurrent/ref...
BACKGROUND: Faecal microbiota transplantation (FMT) is effective for Clostridium difficile infection...
Background: Fecal microbiota transplantation (FMT) is highly effective for treating recurrent Clostr...
ObjectivesAlthough systematic evaluation has confirmed the efficacy of fresh fecal microbiota transp...
Background: Protocols for treating recurrent Clostridium difficile infection (rCDI) through faecal m...
BACKGROUND: Fecal microbiota transplantation (FMT) is highly effective for treating recurrent Clostr...
BACKGROUND:Fecal microbiota transplantation (FMT) via colonoscopy or enema has become a commonly use...
The intestinal microbiome has been identified as a key modifier for a variety of health conditions. ...
Background: Clostridioides difficile infection (CDI) and inflammatory bowel disease (IBD) are globa...
BackgroundFecal microbiota transplantation (FMT) via colonoscopy or enema has become a commonly used...
Background: Faecal microbiota transplantation (FMT) is emerging as a novel therapy for ulcerative co...
Fecal microbiota transplant (FMT) has emerged as a highly efficacious treatment for difficult cases ...
Background Increasing evidence supports the role of the gut microbiota in the aetiology of irritabl...
ObjectivesAlthough systematic evaluation has confirmed the efficacy of fresh fecal microbiota transp...
Introduction: The role of the gut microbiota in health and the pathogenesis of several diseases has ...
Clostridioides difficile infection (CDI) presents a major global healthcare challenge. Recurrent/ref...
BACKGROUND: Faecal microbiota transplantation (FMT) is effective for Clostridium difficile infection...
Background: Fecal microbiota transplantation (FMT) is highly effective for treating recurrent Clostr...
ObjectivesAlthough systematic evaluation has confirmed the efficacy of fresh fecal microbiota transp...
Background: Protocols for treating recurrent Clostridium difficile infection (rCDI) through faecal m...
BACKGROUND: Fecal microbiota transplantation (FMT) is highly effective for treating recurrent Clostr...
BACKGROUND:Fecal microbiota transplantation (FMT) via colonoscopy or enema has become a commonly use...
The intestinal microbiome has been identified as a key modifier for a variety of health conditions. ...
Background: Clostridioides difficile infection (CDI) and inflammatory bowel disease (IBD) are globa...
BackgroundFecal microbiota transplantation (FMT) via colonoscopy or enema has become a commonly used...
Background: Faecal microbiota transplantation (FMT) is emerging as a novel therapy for ulcerative co...
Fecal microbiota transplant (FMT) has emerged as a highly efficacious treatment for difficult cases ...
Background Increasing evidence supports the role of the gut microbiota in the aetiology of irritabl...
ObjectivesAlthough systematic evaluation has confirmed the efficacy of fresh fecal microbiota transp...
Introduction: The role of the gut microbiota in health and the pathogenesis of several diseases has ...
Clostridioides difficile infection (CDI) presents a major global healthcare challenge. Recurrent/ref...